Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity

被引:107
作者
Rivers, EP [1 ]
McIntyre, L
Morro, DC
Rivers, KK
机构
[1] Henry Ford Hosp, Dept Emergency Med, Detroit, MI 48025 USA
[2] Henry Ford Hosp, Dept Surg, Detroit, MI 48025 USA
[3] Henry Ford Hosp, Vatikutti Inst Urol, Detroit, MI 48025 USA
[4] Univ Ottawa, Dept Med Crit Care, Ottawa, ON, Canada
关键词
D O I
10.1503/cmaj.050632
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pathogenic, diagnostic and therapeutic landscape of sepsis is no longer confined to the intensive care unit: many patients from other portals of entry to care, both outside and within the hospital, progress to severe disease. Approaches that have led to improved outcomes with other diseases (e.g., acute myocardial infarction, stroke and trauma) can now be similarly applied to sepsis. Improved understanding of the pathogenesis of severe sepsis and septic shock has led to the development of new therapies that place importance on early identification and aggressive management. This review emphasizes approaches to the early recognition, diagnosis and therapeutic management of sepsis, giving the clinician the most contemporary and practical approaches with which to treat these patients.
引用
收藏
页码:1054 / 1065
页数:12
相关论文
共 162 条
[1]   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[2]   THE USE AND CLINICAL IMPORTANCE OF A SUBSTRATE-SPECIFIC ELECTRODE FOR RAPID-DETERMINATION OF BLOOD LACTATE CONCENTRATIONS [J].
ADUEN, J ;
BERNSTEIN, WK ;
KHASTGIR, T ;
MILLER, JA ;
KERZNER, R ;
BHATIANI, A ;
LUSTGARTEN, J ;
BASSIN, AS ;
DAVISON, L ;
CHERNOW, B .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (21) :1678-1685
[3]   The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome [J].
Aird, WC .
BLOOD, 2003, 101 (10) :3765-3777
[4]   The hematologic system as a marker of organ dysfunction in sepsis [J].
Aird, WC .
MAYO CLINIC PROCEEDINGS, 2003, 78 (07) :869-881
[5]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[6]   Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis [J].
Annane, D ;
Bellissant, E ;
Bollaert, PE ;
Briegel, J ;
Keh, D ;
Kupfer, Y .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7464) :480-484
[7]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[8]  
[Anonymous], 1999, Crit Care Med, V27, P639
[9]   OXYGEN DELIVERY AND CONSUMPTION IN PATIENTS WITH HYPERDYNAMIC SEPTIC SHOCK [J].
ASTIZ, ME ;
RACKOW, EC ;
FALK, JL ;
KAUFMAN, BS ;
WEIL, MH .
CRITICAL CARE MEDICINE, 1987, 15 (01) :26-28
[10]   RELATIONSHIP OF OXYGEN DELIVERY AND MIXED VENOUS OXYGENATION TO LACTIC-ACIDOSIS IN PATIENTS WITH SEPSIS AND ACUTE MYOCARDIAL-INFARCTION [J].
ASTIZ, ME ;
RACKOW, EC ;
KAUFMAN, B ;
FALK, JL ;
WEIL, MH .
CRITICAL CARE MEDICINE, 1988, 16 (07) :655-658